Abstract:Signaling pathways of neurons depend on such factors as the type and "strength" of the synapse, cable properties, distribution of ion channels, and biophysical parameters involved. Aggregation of amyloidbeta (Aβ) in Alzheimer's disease (AD) dramatically affects the functioning of neurons (hippocampal CA1 pyramidal neurons in particular) in multiple ways, which results in loss of memory and cognitive intelligence. To date, the respective available cell models have been focused on individual channel mechanisms involved, without considering the combined effect of those. Due to this, exact information on the respective dysfunction caused in the cell was limited. Therefore, we adopted a methodology analogous to that in studies of neural networks, which takes into account different combinations of the channel mechanisms, to address changes in the number of action potentials (APs) generated (AP counts) in the model. We have taken into consideration decreases in the conductance of A-type potassium channels (KA), delayed rectifier potassium channels (KDR), and sodium channels (Na) in succession to simulate the effect of agglomeration of Aβ. At the same time, we tried to include individual calcium channels, namely L-type (CaL), N-type (CaN), T-type (CaT), and calcium-sensitive potassium channels (Cagk) in unique combinations to identify the behavior and significance of each channel for different input-output relations at locations on the soma and proximal dendrites of the cell. Each of these steps were taken at four distinct AD-influenced stages (30, 60, 90, and 100%). In this study, we found that decreases in the conductance of KA channels induces hyperexcitability, while decreases in the conductance of KDR and Na channels induce hypoexcitability of the neuron. In comparison with KDR, Na channels are highly responsive to CaL, CaN, CaT, and Cagk, and the respective effects are rather significant. In this model, the effects of compensation or rectification on Aβ accumulation were brought about by three methods: first, by altering the conductance of Na channels, second, by reducing the amplitude of input current, and finally, by an equitable combination of both. We found that a higher amount of compensation is required to restore the normal AP counts of the cell under the influence of CaL, as compared with the effects of CaN channels (when each of these are individually included). The model anticipates the potential therapeutic treatments in terms of pharmacological modifications of the channel kinetics.

Unraveling A beta-Mediated Multi-Pathway Calcium Dynamics in Astrocytes: Implications for Alzheimer's Disease Treatment From Simulations

Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.

Simulation of Ca2+ oscillations in astrocytes mediated by amyloid beta in Alzheimer’s disease

Aβ-mediated synaptic glutamate dynamics and calcium dynamics in astrocytes associated with Alzheimer's disease

Computational investigation of Amyloid-β-induced location- and subunit-specific disturbances of NMDAR at hippocampal dendritic spine in Alzheimer’s disease

Astrocytic AT1R deficiency ameliorates Aβ-induced cognitive deficits and synaptotoxicity through β-arrestin2 signaling

Non-Markovian behaviour and the dual role of astrocytes in Alzheimer's disease development and propagation

Data-driven Stochastic Model for Quantifying the Interplay Between Amyloid-beta and Calcium Levels in Alzheimer's Disease

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).

Effects of the Involvement of Calcium Channels on Neuronal Hyperexcitability Related to Alzheimer’s Disease: A Computational Model

Beta-Amyloid Redirects Norepinephrine Signaling To Activate The Pathogenic Gsk3 Beta/Tau Cascade

The important role of glial transmitters released by astrocytes in Alzheimer's disease: A perspective from dynamical modeling

Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells.

Interaction Between A Beta And Tau In The Pathogenesis Of Alzheimer'S Disease

Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss

Elevating the Levels of Calcium Ions Exacerbate Alzheimer’s Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau

Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities.

Altered synaptic plasticity at hippocampal CA1-CA3 synapses in Alzheimer's disease: integration of amyloid precursor protein intracellular domain and amyloid beta effects into computational models

Intracellular A beta and its Pathological Role in Alzheimer's Disease: Lessons from the Cellular to Animal Model

Amyloid-β-induced Alteration of Fast and Localized Calcium Elevations in Cultured Astrocytes

Β-Amyloid Redirects Norepinephrine Signaling to Activate the Pathogenic GSK3β/tau Cascade.